News

Sarepta Stock Soars 30%. Why Layoffs and a ‘Black-Box’ Warning Are Good News.
Sarepta Therapeutics stock soared over 30% after the pharmaceutical company said it would lay off about 500 employees. It ...
BioPharma Dive15h
Sarepta to lay off about 500 employees after Duchenne gene therapy setbacks
The company is also pausing research for several treatments it has been developing for another form of muscular dystrophy.
Sarepta Soars as Gene Therapy Stays on Market With Warning
Sarepta Therapeutics Inc. shares soared after the company said it was cutting more than a third of its workforce and that its ...
GEN - Genetic Engineering and Biotechnology News9h
Sarepta Axes 500, 36% of Workforce, in Restructuring after DMD Patient Deaths
Sarepta Therapeutics said it will eliminate 36% of its workforce—approximately 500 jobs—in a restructuring that follows the ...
Sarepta: Finally, A Little Relief For Bulls; I Expect More
Sarepta's cost-saving moves, FDA surprises, and pipeline potential position SRPT as a unique opportunity. Read here for an ...
The Pharma Letter1h
Sarepta leaps on strategic restructuring and pipeline prioritization
US rare disease meds developer Sarepta Therapeutics late yesterday announced a strategic restructuring plan designed to ...
STAT15h
Sarepta Therapeutics lays off one-third of workforce in drastic cost-cutting move
Sarepta Therapeutics announced it has laid off more than one-third of its workforce, a drastic cost-cutting move following ...
Stocks to Watch Thursday: TSMC, United Airlines, Sarepta
The world's largest contract chip maker delivered a record profit last quarter, as demand held up [despite tariff-related uncertainty]( ...